Confirming this suggestion, both NAFLD and metabolic syndrome are associated with lower serum GH levels and lower GH and IGF-1 levels were consistently reported in NAFLD patients compared to NAFLD-free controls [135,136,137,138,139]. This evidence concerns the gene GH1 and metabolic dysfunction-associated steatotic liver disease.